USRE38115E1 - Dextromethorphan and an oxidase inhibitor for treating intractable conditions - Google Patents

Dextromethorphan and an oxidase inhibitor for treating intractable conditions Download PDF

Info

Publication number
USRE38115E1
USRE38115E1 US10/052,698 US5269802A USRE38115E US RE38115 E1 USRE38115 E1 US RE38115E1 US 5269802 A US5269802 A US 5269802A US RE38115 E USRE38115 E US RE38115E
Authority
US
United States
Prior art keywords
dextromethorphan
quinidine
dm
pharmaceutically acceptable
method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US10/052,698
Inventor
Richard Alan Smith
Jonathan M. Licht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AVANIR PHARMACEUTICALS Inc
Original Assignee
Center for Neurologic Study
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Application filed by Center for Neurologic Study filed Critical Center for Neurologic Study
Priority to US08/464,792 priority Critical patent/US5863927A/en
Priority to US10/052,698 priority patent/USRE38115E1/en
Priority to PCT/US1994/010771 priority patent/WO1996009044A1/en
Application granted granted Critical
Publication of USRE38115E1 publication Critical patent/USRE38115E1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22243021&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=USRE38115(E1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Assigned to CENTER FOR NEUROLOGIC STUDY reassignment CENTER FOR NEUROLOGIC STUDY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SMITH, RICHARD A., MD
Anticipated expiration legal-status Critical
Assigned to AVANIR PHARMACEUTICALS, INC. reassignment AVANIR PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CENTER FOR NEUROLOGIC STUDY
Application status is Expired - Lifetime legal-status Critical

Links